Criteo: Good Momentum, But Still Undervalued (NASDAQ:CRTO)

Daniel Grizelj/DigitalVision via Getty Images Investment Thesis Criteo (NASDAQ:CRTO) is showing strong momentum in its transition into a fast-growing adtech software provider. Upgraded management guidance for 2024 revenue and EBITDA has resulted in a 16% return since our last article three months ago, on February 15th 2024. However, Criteo’s EBITDA multiple has remained largely flat….

Read More

Pagaya: An Undervalued Fintech Powerhouse (NASDAQ:PGY)

Daniel Grizelj Since posting strong Q1 results, Pagaya Technologies Ltd. (NASDAQ:PGY) has climbed nearly 21%. The company showed strong growth in network volume, revenues, and adjusted EBITDA, while also sharing a strong full year guidance. In my opinion, Pagaya could continue witnessing substantial growth due to its expansion in the fast growing POS financing vertical,…

Read More

Lesaka: An Undervalued Fintech Gem (NASDAQ:LSAK)

FG Trade Investment Thesis Since we last covered Lesaka Technologies, Inc. (NASDAQ:LSAK), the largest fintech company in South Africa, the company has made significant progress in its turnaround efforts, made another acquisition, upgraded management, and is now ready to accelerate growth. However, the stock price has not yet fully reflected these developments. Outgoing CEO Chris…

Read More

Kaiser Aluminum: Undervalued With High Dividend Growth Potential

Yuji Sakai Kaiser Aluminum Corporation (NASDAQ:KALU) recently reported better than expected quarterly earnings, and the outlook for 2024 includes net sales growth and EBITDA growth. With a diversified product offering, KALU also promised net debt/EBITDA reduction, lean manufacturing, and other operational efficiency efforts, which may bring net income growth and dividend growth in the coming…

Read More

STMicroelectronics Is Significantly Undervalued With High Growth Potential (NYSE:STM)

JHVEPhoto There are many semiconductor companies to choose from, and many offer compelling valuations and future operational and financial advantages. However, at this time, STMicroelectronics N.V. (NYSE:STM) looks like one of the most compelling. While TSMC (TSM) has become what I consider overvalued at this time, STM remains positioned for an attractive entry. Overview &…

Read More

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Just_Super/iStock via Getty Images Medtronic PLC (NYSE:MDT) is a global developer and manufacturer of medical devices for chronic diseases. Founded in 1949, Medtronic is now a $111 billion (by market cap) healthcare behemoth that employs 95,000 people. The company reports results across four segments: Cardiovascular, 37% of FY 2023 revenue; Neuroscience, 29%; Medical Surgical, 27%;…

Read More

Veolia: Undervalued Environmental Services Leader (OTCMKTS:VEOEF)

Teamjackson We present our note on Veolia Environnement SA (OTCPK:VEOEF) (OTCPK:VEOEY), the leading global provider of environmental services to municipal and industrial clients, with a Buy rating. We are drawn by Veolia’s exposure to structural tailwinds, cost-cutting efforts, synergies execution leading to significant growth CAGR, dividend coverage, and a cheap valuation. We see the upcoming…

Read More

Banco Santander Remains Materially Undervalued (NYSE:SAN)

MarioGuti Shares of Banco Santander (NYSE:SAN) have underwhelmed since I last covered the Spanish multinational banking giant in October. The ADSs have delivered a circa 9% total return in that time, roughly matching domestic-oriented peer CaixaBank (OTCPK:CAIXY)(OTCPK:CIXPF) but trailing similarly Spanish/LatAm-focused BBVA (BBVA) as well as European financials (EUFN) more generally. Data by YCharts I…

Read More

Box: Undervalued SaaS Play With New Growth Drivers (NYSE:BOX)

Andriy Onufriyenko/Moment via Getty Images Box (NYSE:BOX) offers a compelling risk/reward at current levels in my view. The leading Content Cloud player trails peers on growth but deserves a better multiple given improving margins, new product catalysts, and secular tailwinds for secure collaboration. After years of inconsistent execution, Box may finally be poised to accelerate…

Read More

International Money Express: Potentially Undervalued, But With Balance Sheet Risks

Viorika International Money Express (NASDAQ:IMXI) looks like a strong addition to portfolios looking for stable growth and relatively low risk at this time. The company’s shares look undervalued to me despite P/E ratio concerns, and profitability weaknesses could be eased through operational shifts. Operations International Money Express, or Intermex, is a specialist in money remittance…

Read More

Elevance Health Q4: Undervalued Despite Risks To Core Business (NYSE:ELV)

mediaphotos Elevance Health, Inc. (NYSE:ELV) reported earnings on January 24th with a favorable reception. Elevance Health is the largest commercial insurance company in the United States. Its comprehensive business model centers on ‘whole health’. Elevance Health’s services extend across various domains of healthcare. These include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans…

Read More

Samsonite International: Undervalued With Growth Drivers And Catalysts

Shawn Williams/iStock Editorial via Getty Images Elevator Pitch My investment rating for Samsonite International S.A. (OTCPK:SMSOF) [1910:HK] stays as a Buy. I previously wrote about Samsonite International’s Q1 2021 performance and full-year fiscal 2021 business prospects in an article published on June 17, 2021. The focus of the current write-up is Samsonite International’s near-term financial…

Read More

Most Undervalued Asset Classes, Equity Industries, Segments, And Regions – 2024

Pgiam/iStock via Getty Images The J.P. Morgan Guide to the Markets is exactly what it says on the tin: a comprehensive, in-depth guide to global investment markets. It includes a treasure trove of quantitative information regarding U.S. and international equities, bonds, and other investment securities, as well as broader macroeconomic conditions. The guide includes detailed…

Read More

Reckitt Benckiser Stock: Undervalued With Sound Growth Prospects (OTCMKTS:RBGLY)

Hitra British consumer staples giant Reckitt Benckiser (OTCPK:RBGLY)(OTCPK:RBGPF) has continued to underwhelm, with the dollar-denominated ADSs underperforming the global peer group by circa 12ppt over the past couple of years. Performance has been similarly disappointing since I last covered the company on Seeking Alpha back in 2021, with a negative 15% total return representing nearly…

Read More

Moderna’s Flu/COVID Vaccine Prospects Are Undervalued By The Market (NASDAQ:MRNA)

Jelena Stanojkovic/iStock via Getty Images At a Glance Delving into Moderna’s (NASDAQ:MRNA) trajectory, my earlier analysis shed light on its eclectic project range. This spectrum spans from oncology to infectious diseases, with notable breakthroughs in RSV and flu vaccines. Moderna has since leaped forward, especially with mRNA-1083. This vaccine, both innovative and dual-purpose, targets COVID-19…

Read More